(IQV) – Management Comments
-
IQVIA Holdings (IQV) Tops Q4 EPS by 11c, Revenues Beat; Raises FY21 EPS/Revenue Guidance, Offers 1Q EPS/Revenue Guidance Above Consensus
-
Mateon Therapeutics (MATN) to Select IQVIA (IQV) for Randomized, Controlled, Multi-Center Clinical Study of Test OT-101
-
-
-
-
-
-
-
-
-
-
Back to IQV Stock Lookup